Thyroid Gland Anaplastic Carcinoma — Trials

Thyroid Gland Anaplastic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

61 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 22
Recruiting: 9
Ph III recruiting: 2
Growth YoY: —
Industry share: 9%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06902376	XL092 and Cemiplimab in BRAF WT Thyroid Cancer(NEO-COMBATXL)	recruiting	Phase 1	12	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Sep 8, 2026	clinicaltrials
NCT03975231	Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer	recruiting	Phase 1	6	City of Hope Medical CenterOTHER	1	Apr 8, 2026	clinicaltrials